LA
DGX icon

LBP AM’s Quest Diagnostics DGX Stock Holding History

LBP AM’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,632
Closed -$3.66M – 377
2025
Q1 		$3.66M Sell
21,632
-840
-4% -$138K 0.06% 227
2024
Q4 		$3.39M Buy
22,472
+14,996
+201% +$2.33M 0.05% 233
2024
Q3 		$1.16M Sell
7,476
-1
-0% -$149 0.02% 283
2024
Q2 		$1.02M Buy
7,477
+461
+7% +$63.1K 0.04% 214
2024
Q1 		$934K Buy
7,016
+3,656
+109% +$474K 0.04% 247
2023
Q4 		$463K Hold
3,360
– – 0.01% 393
2023
Q3 		$409K Sell
3,360
-1,528
-31% -$204K 0.01% 447
2023
Q2 		$687K Sell
4,888
-17,954
-79% -$2.48M 0.02% 362
2023
Q1 		$3.23M Sell
22,842
-1,118
-5% -$160K 0.08% 215
2022
Q4 		$3.75M Buy
+23,960
New +$3.44M 0.11% 192

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LBP AM's DGX Position: Q2 2025 in Review

LBP AM sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 21,632 shares — an estimated $3.66M sold.

LBP AM first reported a position in DGX in Q4 2022 and held it in 10 quarters. The position peaked at $3.75M in Q4 2022. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • LBP AM reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • LBP AM sold 21,632 Quest Diagnostics shares in Q2 2025, an estimated $3.66M.
  • LBP AM first reported a position in Quest Diagnostics in Q4 2022 and held it in 10 quarters.
  • LBP AM's Quest Diagnostics position peaked at $3.75M in Q4 2022.
  • 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on LBP AM's 13F filing for Q2 2025, filed 18 Jul 2025.